Tear film osmolarity measurements can diagnose dry eye disease

Article

Measuring tear film osmolarity is very effective in diagnosing dry eye disease.

Measuring tear film osmolarity is very effective in diagnosing dry eye disease, according to a paper published in Cornea.

The investigation led by Dr Christina Jacobi, Department of Ophthalmology, University of Erlangen-Nuremberg, Erlangen, Germany, involved 133 patients with moderate to severe keratoconjunctivitus sicca and 95 control participants. Each participant had tear samples taken directly from the inferior lateral tear meniscus. The TearLab osmometer was used to analyse tear film osmolarity.

The inclusion criteria was a Schirmer test with anaesthesia of less than 5 mm, a tear breakup time of less than 5 seconds and positive symptoms where the Ocular Surface Disease Index Score was over 83.

A tear film osmolarity of 320 mOsmol/L was found in the patients with moderate to severe keratoconjunctivitis. The control group presented with a tear film osmolarity of 301 mOsmol/L. Tear film osmolarity was significantly higher in patients with moderate to severe keratoconjunctivitus sicca compared to the control group. The study also confirmed that the official referent value in moderate to severe dry eye was approximately 316 mOsmol/L.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.